Veravas Launches VeraBIND™ Tau – First Blood Test to Detect Alzheimer’s-Related Tau Pathology

New non-invasive test offers 96% sensitivity and 90% specificity, empowering earlier and more accessible Alzheimer’s detection AUSTIN, Texas, April 22, 2025 /PRNewswire/ — Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the…